$KPTI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Karyopharm Therapeutics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Karyopharm Therapeutics Inc.. Get notifications about new insider transactions in Karyopharm Therapeutics Inc. for free.
Page: < prev 1 2 3 4 5 6 ... 6 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 7,500 | 35,640 | 763,989 | 756.5 K to 764 K (+0.99 %) |
| Jun 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 18.13 | 7,500 | 135,944 | 555,122 | 562.6 K to 555.1 K (-1.33 %) |
| Jun 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 7,500 | 35,640 | 562,622 | 555.1 K to 562.6 K (+1.35 %) |
| Jun 11 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 4.75 | 7,500 | 35,640 | 341,061 | |
| Jun 11 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 4.75 | 7,500 | 35,640 | 385,303 | |
| Jun 11 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 18.13 | 7,500 | 135,944 | 555,122 | 562.6 K to 555.1 K (-1.33 %) |
| Jun 11 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 4.75 | 7,500 | 35,640 | 562,622 | 555.1 K to 562.6 K (+1.35 %) |
| Jun 11 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 18.50 | 7,500 | 138,746 | 756,489 | 764 K to 756.5 K (-0.98 %) |
| Jun 11 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 4.75 | 7,500 | 35,640 | 763,989 | 756.5 K to 764 K (+0.99 %) |
| May 26 2020 | KPTI | Karyopharm Therape ... | Paulson Richard A. | Director | Option Exercise | A | 19.11 | 16,400 | 313,404 | 16,400 | |
| May 26 2020 | KPTI | Karyopharm Therape ... | PAKIANATHAN DEEPIKA | Director | Option Exercise | A | 19.11 | 16,400 | 313,404 | 16,400 | |
| May 26 2020 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Option Exercise | A | 19.11 | 16,400 | 313,404 | 16,400 | |
| May 26 2020 | KPTI | Karyopharm Therape ... | Greene Barry E | Director | Option Exercise | A | 19.11 | 16,400 | 313,404 | 16,400 | |
| May 26 2020 | KPTI | Karyopharm Therape ... | BOHLIN GAREN G | Director | Option Exercise | A | 19.11 | 16,400 | 313,404 | 16,400 | |
| May 19 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.03 | 7,500 | 248 | 357 | |
| May 19 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.03 | 7,500 | 248 | 7,857 | |
| May 19 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 20.00 | 7,500 | 150,000 | 756,489 | 764 K to 756.5 K (-0.98 %) |
| May 19 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.03 | 7,500 | 248 | 763,989 | 756.5 K to 764 K (+0.99 %) |
| May 19 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 18.65 | 7,500 | 139,841 | 756,489 | 764 K to 756.5 K (-0.98 %) |
| May 19 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.03 | 7,500 | 248 | 763,989 | 756.5 K to 764 K (+0.99 %) |
| May 19 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 0.03 | 7,500 | 248 | 357 | |
| May 19 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 0.03 | 7,500 | 248 | 7,857 | |
| May 19 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 20.00 | 7,500 | 150,000 | 756,489 | 764 K to 756.5 K (-0.98 %) |
| May 19 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 0.03 | 7,500 | 248 | 763,989 | 756.5 K to 764 K (+0.99 %) |
| May 19 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 18.65 | 7,500 | 139,841 | 756,489 | 764 K to 756.5 K (-0.98 %) |
| May 19 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 0.03 | 7,500 | 248 | 763,989 | 756.5 K to 764 K (+0.99 %) |
| May 11 2020 | KPTI | Karyopharm Therape ... | Frenkel Ran | Chief Dev Operation ... | Sell | S | 20.00 | 1,974 | 39,480 | 35,088 | 37.1 K to 35.1 K (-5.33 %) |
| May 11 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Option Exercise | M | 6.54 | 2,946 | 19,267 | 10,054 | |
| May 11 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 20.00 | 2,946 | 58,920 | 4,649 | 7.6 K to 4.6 K (-38.79 %) |
| May 11 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Buy | M | 6.54 | 2,946 | 19,267 | 7,595 | 4.6 K to 7.6 K (+63.37 %) |
| May 11 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 19.62 | 6,714 | 131,707 | 4,649 | 11.4 K to 4.6 K (-59.09 %) |
| May 11 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 4.75 | 7,500 | 35,640 | 348,561 | |
| May 11 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 4.75 | 7,500 | 35,640 | 392,803 | |
| May 11 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 19.63 | 7,500 | 147,209 | 555,122 | 562.6 K to 555.1 K (-1.33 %) |
| May 11 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 4.75 | 7,500 | 35,640 | 562,622 | 555.1 K to 562.6 K (+1.35 %) |
| May 11 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 19.63 | 7,500 | 147,205 | 756,489 | 764 K to 756.5 K (-0.98 %) |
| May 11 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 4.75 | 7,500 | 35,640 | 763,989 | 756.5 K to 764 K (+0.99 %) |
| Apr 10 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 10,000 | 47,520 | 400,303 | |
| Apr 10 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 10,000 | 47,520 | 356,061 | |
| Apr 10 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 18.61 | 10,000 | 186,115 | 756,489 | 766.5 K to 756.5 K (-1.30 %) |
| Apr 10 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 10,000 | 47,520 | 766,489 | 756.5 K to 766.5 K (+1.32 %) |
| Apr 10 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 20.64 | 10,000 | 206,404 | 555,122 | 565.1 K to 555.1 K (-1.77 %) |
| Apr 10 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 10,000 | 47,520 | 565,122 | 555.1 K to 565.1 K (+1.80 %) |
| Apr 10 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 4.75 | 10,000 | 47,520 | 356,061 | |
| Apr 10 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 4.75 | 10,000 | 47,520 | 400,303 | |
| Apr 10 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 20.64 | 10,000 | 206,404 | 555,122 | 565.1 K to 555.1 K (-1.77 %) |
| Apr 10 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 4.75 | 10,000 | 47,520 | 565,122 | 555.1 K to 565.1 K (+1.80 %) |
| Apr 10 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 18.61 | 10,000 | 186,115 | 756,489 | 766.5 K to 756.5 K (-1.30 %) |
| Apr 10 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 4.75 | 10,000 | 47,520 | 766,489 | 756.5 K to 766.5 K (+1.32 %) |
| Mar 17 2020 | KPTI | Karyopharm Therape ... | Greene Barry E | Director | Option Exercise | M | 0.03 | 3,030 | 100 | 0 | |
| Mar 17 2020 | KPTI | Karyopharm Therape ... | Greene Barry E | Director | Buy | M | 0.03 | 3,030 | 100 | 6,030 | 3 K to 6 K (+101.00 %) |
| Mar 17 2020 | KPTI | Karyopharm Therape ... | DEMAREE JOHN | Chief Commercial Of ... | Option Exercise | A | 16.50 | 151,200 | 2,494,800 | 151,200 | |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 4.75 | 10,000 | 47,520 | 366,061 | |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 4.75 | 10,000 | 47,520 | 410,303 | |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 22.64 | 2,068 | 46,821 | 555,122 | 557.2 K to 555.1 K (-0.37 %) |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 22.11 | 7,932 | 175,365 | 557,190 | 565.1 K to 557.2 K (-1.40 %) |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 4.75 | 10,000 | 47,520 | 565,122 | 555.1 K to 565.1 K (+1.80 %) |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 22.38 | 3,000 | 67,141 | 756,489 | 759.5 K to 756.5 K (-0.40 %) |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 22.58 | 7,000 | 158,054 | 759,489 | 766.5 K to 759.5 K (-0.91 %) |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 4.75 | 10,000 | 47,520 | 766,489 | 756.5 K to 766.5 K (+1.32 %) |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 10,000 | 47,520 | 410,303 | |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 10,000 | 47,520 | 366,061 | |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 22.38 | 3,000 | 67,141 | 756,489 | 759.5 K to 756.5 K (-0.40 %) |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 22.58 | 7,000 | 158,054 | 759,489 | 766.5 K to 759.5 K (-0.91 %) |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 10,000 | 47,520 | 766,489 | 756.5 K to 766.5 K (+1.32 %) |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 22.64 | 2,068 | 46,821 | 555,122 | 557.2 K to 555.1 K (-0.37 %) |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 22.11 | 7,932 | 175,365 | 557,190 | 565.1 K to 557.2 K (-1.40 %) |
| Mar 11 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 10,000 | 47,520 | 565,122 | 555.1 K to 565.1 K (+1.80 %) |
| Mar 09 2020 | KPTI | Karyopharm Therape ... | Paulson Richard A. | Director | Option Exercise | A | 26.12 | 50,000 | 1,306,000 | 50,000 | |
| Mar 04 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Option Exercise | M | 10.39 | 26,500 | 275,335 | 76,500 | |
| Mar 04 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 24.00 | 9,000 | 216,029 | 10,367 | 19.4 K to 10.4 K (-46.47 %) |
| Mar 04 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 28.00 | 10,000 | 280,000 | 19,367 | 29.4 K to 19.4 K (-34.05 %) |
| Mar 04 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 23.50 | 7,500 | 176,250 | 29,367 | 36.9 K to 29.4 K (-20.34 %) |
| Mar 04 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Buy | M | 10.39 | 26,500 | 275,335 | 36,867 | 10.4 K to 36.9 K (+255.62 %) |
| Mar 04 2020 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Option Exercise | M | 8.06 | 5,000 | 40,300 | 0 | |
| Mar 04 2020 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Sell | S | 23.50 | 5,000 | 117,500 | 0 | 5 K to 0 (-100.00 %) |
| Mar 04 2020 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Buy | M | 8.06 | 5,000 | 40,300 | 5,000 | 0 to 5 K |
| Feb 21 2020 | KPTI | Karyopharm Therape ... | Shah Jatin | EVP, Chief Medical ... | Sell | S | 16.48 | 1,375 | 22,663 | 40,759 | 42.1 K to 40.8 K (-3.26 %) |
| Feb 21 2020 | KPTI | Karyopharm Therape ... | Frenkel Ran | Chief Dev Operation ... | Sell | S | 16.48 | 2,975 | 49,034 | 36,066 | 39 K to 36.1 K (-7.62 %) |
| Feb 21 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 16.48 | 2,961 | 48,803 | 10,367 | 13.3 K to 10.4 K (-22.22 %) |
| Feb 21 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 16.48 | 8,817 | 145,321 | 555,122 | 563.9 K to 555.1 K (-1.56 %) |
| Feb 21 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 16.48 | 8,817 | 145,321 | 756,489 | 765.3 K to 756.5 K (-1.15 %) |
| Feb 21 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 16.48 | 8,817 | 145,321 | 756,489 | 765.3 K to 756.5 K (-1.15 %) |
| Feb 21 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 16.48 | 8,817 | 145,321 | 555,122 | 563.9 K to 555.1 K (-1.56 %) |
| Feb 19 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.00 | 21,800 | 0 | 65,400 | |
| Feb 19 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.00 | 21,800 | 0 | 65,400 | |
| Feb 19 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.00 | 21,800 | 0 | 765,306 | 743.5 K to 765.3 K (+2.93 %) |
| Feb 19 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.00 | 21,800 | 0 | 563,939 | 542.1 K to 563.9 K (+4.02 %) |
| Feb 07 2020 | KPTI | Karyopharm Therape ... | Lewis Tanya | EVP,Chief Reg.&Qual ... | Option Exercise | A | 0.00 | 22,600 | 0 | 22,600 | |
| Feb 07 2020 | KPTI | Karyopharm Therape ... | Lewis Tanya | EVP,Chief Reg.&Qual ... | Option Exercise | A | 18.00 | 60,600 | 1,090,800 | 60,600 | |
| Feb 07 2020 | KPTI | Karyopharm Therape ... | Shah Jatin | EVP, Chief Medical ... | Option Exercise | A | 0.00 | 22,600 | 0 | 22,600 | |
| Feb 07 2020 | KPTI | Karyopharm Therape ... | Shah Jatin | EVP, Chief Medical ... | Option Exercise | A | 18.00 | 60,600 | 1,090,800 | 60,600 | |
| Feb 07 2020 | KPTI | Karyopharm Therape ... | Mason Michael | SVP, CFO & Treasure ... | Option Exercise | A | 0.00 | 32,600 | 0 | 32,600 | |
| Feb 07 2020 | KPTI | Karyopharm Therape ... | Mason Michael | SVP, CFO & Treasure ... | Option Exercise | A | 18.00 | 87,600 | 1,576,800 | 87,600 | |
| Feb 07 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Option Exercise | A | 0.00 | 30,300 | 0 | 30,300 | |
| Feb 07 2020 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Option Exercise | A | 18.00 | 81,200 | 1,461,600 | 81,200 | |
| Feb 07 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | A | 0.00 | 57,200 | 0 | 57,200 | |
| Feb 07 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | A | 0.00 | 57,200 | 0 | 57,200 | |
| Feb 07 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | A | 18.00 | 153,500 | 2,763,000 | 153,500 | |
| Feb 07 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | A | 18.00 | 153,500 | 2,763,000 | 153,500 | |
| Jan 13 2020 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Option Exercise | M | 8.06 | 2,056 | 16,571 | 5,000 | |
| Jan 13 2020 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Sell | S | 20.00 | 2,056 | 41,120 | 0 | 2.1 K to 0 (-100.00 %) |
| Jan 13 2020 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Buy | M | 8.06 | 2,056 | 16,571 | 2,056 | 0 to 2.1 K |
| Jan 10 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 10,000 | 47,520 | 430,303 | |
| Jan 10 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 10,000 | 47,520 | 386,061 | |
| Jan 10 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Gift | G | 0.00 | 17,313 | 0 | 0 | 17.3 K to 0 (-100.00 %) |
| Jan 10 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Gift | G | 0.00 | 17,313 | 0 | 0 | 17.3 K to 0 (-100.00 %) |
| Jan 10 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 18.57 | 10,000 | 185,705 | 743,506 | 753.5 K to 743.5 K (-1.33 %) |
| Jan 10 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 10,000 | 47,520 | 753,506 | 743.5 K to 753.5 K (+1.34 %) |
| Jan 10 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 19.19 | 10,000 | 191,880 | 542,139 | 552.1 K to 542.1 K (-1.81 %) |
| Jan 10 2020 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 10,000 | 47,520 | 552,139 | 542.1 K to 552.1 K (+1.84 %) |
| Jan 10 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 4.75 | 10,000 | 47,520 | 386,061 | |
| Jan 10 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 4.75 | 10,000 | 47,520 | 430,303 | |
| Jan 10 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Gift | G | 0.00 | 17,313 | 0 | 0 | 17.3 K to 0 (-100.00 %) |
| Jan 10 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Gift | G | 0.00 | 17,313 | 0 | 0 | 17.3 K to 0 (-100.00 %) |
| Jan 10 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 19.19 | 10,000 | 191,880 | 542,139 | 552.1 K to 542.1 K (-1.81 %) |
| Jan 10 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 4.75 | 10,000 | 47,520 | 552,139 | 542.1 K to 552.1 K (+1.84 %) |
| Jan 10 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 18.57 | 10,000 | 185,705 | 743,506 | 753.5 K to 743.5 K (-1.33 %) |
| Jan 10 2020 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 4.75 | 10,000 | 47,520 | 753,506 | 743.5 K to 753.5 K (+1.34 %) |
| Dec 31 2019 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Option Exercise | M | 8.06 | 2,944 | 23,729 | 7,056 | |
| Dec 31 2019 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Sell | S | 20.00 | 2,944 | 58,880 | 0 | 2.9 K to 0 (-100.00 %) |
| Dec 31 2019 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Buy | M | 8.06 | 2,944 | 23,729 | 2,944 | 0 to 2.9 K |
| Dec 31 2019 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Option Exercise | M | 10.39 | 5,000 | 51,950 | 103,000 | |
| Dec 31 2019 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 20.00 | 5,000 | 100,000 | 3,653 | 8.7 K to 3.7 K (-57.78 %) |
| Dec 31 2019 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Buy | M | 10.39 | 5,000 | 51,950 | 8,653 | 3.7 K to 8.7 K (+136.87 %) |
| Dec 20 2019 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Option Exercise | M | 1.49 | 12,121 | 18,000 | 0 | |
| Dec 20 2019 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Sell | S | 17.18 | 7,121 | 122,345 | 0 | 7.1 K to 0 (-100.00 %) |
| Dec 20 2019 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Sell | S | 17.18 | 5,000 | 85,891 | 7,121 | 12.1 K to 7.1 K (-41.25 %) |
| Dec 20 2019 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Buy | M | 1.49 | 12,121 | 18,000 | 12,121 | 0 to 12.1 K |
| Dec 11 2019 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Option Exercise | M | 5.64 | 10,342 | 58,360 | 0 | |
| Dec 11 2019 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Sell | S | 17.02 | 5,342 | 90,926 | 0 | 5.3 K to 0 (-100.00 %) |
| Dec 11 2019 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Sell | S | 17.02 | 5,000 | 85,108 | 5,342 | 10.3 K to 5.3 K (-48.35 %) |
| Dec 11 2019 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Buy | M | 5.64 | 10,342 | 58,360 | 10,342 | 0 to 10.3 K |
| Dec 11 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 10,000 | 47,520 | 440,303 | |
| Dec 11 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 10,000 | 47,520 | 396,061 | |
| Dec 11 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 17.02 | 10,000 | 170,210 | 731,134 | 741.1 K to 731.1 K (-1.35 %) |
| Dec 11 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 10,000 | 47,520 | 741,134 | 731.1 K to 741.1 K (+1.37 %) |
| Dec 11 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 15.99 | 10,000 | 159,896 | 529,767 | 539.8 K to 529.8 K (-1.85 %) |
| Dec 11 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 10,000 | 47,520 | 539,767 | 529.8 K to 539.8 K (+1.89 %) |
| Dec 11 2019 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 4.75 | 10,000 | 47,520 | 396,061 | |
| Dec 11 2019 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 4.75 | 10,000 | 47,520 | 440,303 | |
| Dec 11 2019 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 15.99 | 10,000 | 159,896 | 529,767 | 539.8 K to 529.8 K (-1.85 %) |
| Dec 11 2019 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 4.75 | 10,000 | 47,520 | 539,767 | 529.8 K to 539.8 K (+1.89 %) |
| Dec 11 2019 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 17.02 | 10,000 | 170,210 | 731,134 | 741.1 K to 731.1 K (-1.35 %) |
| Dec 11 2019 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 4.75 | 10,000 | 47,520 | 741,134 | 731.1 K to 741.1 K (+1.37 %) |
| Dec 10 2019 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Option Exercise | M | 10.39 | 5,000 | 51,950 | 108,000 | |
| Dec 10 2019 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Option Exercise | M | 6.54 | 5,000 | 32,700 | 13,000 | |
| Dec 10 2019 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 17.46 | 3,000 | 52,368 | 3,653 | 6.7 K to 3.7 K (-45.09 %) |
| Dec 10 2019 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 17.45 | 5,000 | 87,256 | 6,653 | 11.7 K to 6.7 K (-42.91 %) |
| Dec 10 2019 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | EVP, CBO, GC & Secr ... | Sell | S | 17.46 | 5,000 | 87,284 | 11,653 | 16.7 K to 11.7 K (-30.02 %) |